On the Record · Forward Pharma A/S
Forward Pharma A/S acquisitions, on the record
The businesses Forward Pharma A/S bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Aditech patent family and associated know-how (formulations and dosing regimens of DMF)Word for word“In 2010, we acquired this patent family from Aditech pursuant to a patent transfer agreement, or the Transfer Agreement, that replaced the patent license agreement.” 20-F for 2019 | acquisition | 2010 | — |
Aditech Pharma AB's Core Composition Patent family (Aditech Pharma AB and its successor Aditech Pharma AG)Word for word“In 2010, the Company acquired this patent family from Aditech pursuant to the Transfer Agreement that replaced the patent license agreement.” 20-F for 2020 | acquisition | — | — |
Read from Forward Pharma A/S’s annual reports (20-F for 2021, 20-F for 2020, 20-F for 2019) and the financial data it files with the SEC, as of 2022-04-08. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.